While widespread spliceosomal dysfunction has not yet been directly reported in CDKL5 deficiency, transcriptomic analyses in CDD models have revealed altered expression of genes involved in RNA metabolism and post-transcriptional regulation [63,107], supporting the hypothesis that splicing impairments may contribute to the molecular pathology. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.